Price T Rowe Associates Inc Amneal Pharmaceuticals, Inc. Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 86,027 shares of AMRX stock, worth $731,229. This represents 0.0% of its overall portfolio holdings.
Number of Shares
86,027
Previous 81,264
5.86%
Holding current value
$731,229
Previous $493,000
10.95%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding AMRX
# of Institutions
184Shares Held
138MCall Options Held
234KPut Options Held
45.9K-
Ubs Group Ag21.8MShares$186 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$119 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$105 Million1.95% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$95.9 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$91.1 Million2.02% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.29B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...